NanoGroup S.A. (WSE:NNG)

Market Cap	104.87M +19.0%
Revenue (ttm)	2.89M +1,718.4%
Net Income	-11.52M
EPS	n/a
Shares Out	42.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,922
Open	2.475
Previous Close	2.480
Day's Range	2.440 - 2.475
52-Week Range	2.175 - 3.200
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A. was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 1, 2026

Data Sources Report a data error